MustGrow Closes $3.9 Million Private Placement
10 Dezembro 2019 - 7:00PM
MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF)
(the "
Company", "
MustGrow"), an
agricultural biotech company developing and commercializing a
portfolio of natural, science-based bio-pesticides, is pleased to
announce it has closed its previously-announced non-brokered
private placement (the “
Private Placement”).
MustGrow has closed on an aggregate of 11,139,879 units for gross
proceeds of C$3,898,957.
The Private Placement consists of units (each a
“Unit”) at a price per Unit of C$0.35. Each Unit
shall consist of one common share of the Company and one-half of
one common share purchase warrant (each a
“Warrant”). Each full Warrant shall entitle the
holder to acquire one common share of the Company at a price of
C$0.50 for a period of 24 months following the closing of the
Private Placement.
The Company intends to use the proceeds from the
Private Placement to fund research and development, and for working
capital and general corporate purposes.
MustGrow advises that certain insiders of the
Company are participating in the Private Placement which will be
completed pursuant to available related party exemptions under
Multilateral Instrument 61-101 (Protection of Minority Security
Holders in Special Transactions).
All securities issued under the Private
Placement will be subject to a hold period expiring April 11, 2020,
equivalent to 4 months plus 1 day following the closing date of the
Private Placement. The Private Placement is subject to certain
conditions including, but not limited to, the receipt of all
necessary approvals, including the approval of the Canadian
Securities Exchange and the applicable securities regulatory
authorities. The Company paid a total of C$188,345 cash and 534,987
broker warrants as finders’ fees in connection with the Private
Placement.
The securities have not been and will not be
registered under the U.S. Securities Act of 1933, as amended (the
“U.S. Securities Act”), or any U.S. state
securities laws, and may not be offered or sold in the United
States or to, or for the account or benefit of, United States
persons absent registration or an applicable exemption from the
registration requirements of the U.S. Securities Act and applicable
U.S. state securities laws. This press release shall not constitute
an offer to sell or the solicitation of an offer to buy securities
in the United States, nor shall there be any sale of these
securities in any jurisdiction in which such offer, solicitation or
sale would be unlawful.
About MustGrow
MustGrow is a publicly traded (CSE:
MGRO) (OTC: MGROF) agricultural biotech company focused on
providing natural science-based biological solutions for high value
crops, including fruit & vegetable and cannabis cultivation.
MustGrow has designed and owns a United States EPA-approved organic
solution that uses the mustard seed’s natural defence mechanism to
protect plants from pests and diseases. 110 independent tests have
been completed, validating MustGrow’s safe and effective signature
products. This product, in granule format, is EPA-approved across
all key U.S. states as a fertilizer and pesticide (currently
limited to fertilizer in California) and is designated by Health
Canada’s PMRA (Pest Management Regulatory Agency) as a fruit &
vegetable bio-pesticide and fertilizer. MustGrow has now
concentrated a liquid format to be applied through standard drip or
spray equipment, improving functionality and performance
features.
In cannabis, MustGrow is currently developing
effective, safe and biological solutions that adhere to Health
Canada’s strict regulations, including (1) its mustard-derived
bio-pesticide to treat soil-borne pests and diseases; and (2) an
in-licensed bio-fungicide for powdery mildew.
The Company has approximately 36.1 million basic
common shares issued and outstanding. For further details please
visit www.mustgrow.ca.
ON BEHALF OF THE BOARD
"Corey Giasson"
Director & CEO Phone: +1-306-668-2652
Forward-Looking Statements
Certain statements included in this press
release constitute "forward-looking statements" which involve known
and unknown risks, uncertainties and other factors that may affect
the results, performance or achievements of MustGrow.
Generally, forward-looking information can be
identified by the use of forward-looking terminology such as
"plans", "expects", "is expected", "budget", "estimates",
"intends", "anticipates" or "does not anticipate", or "believes",
or variations of such words and phrases or statements that certain
actions, events or results "may", "could", "would", "might",
"occur" or "be achieved".
Forward-looking statements are subject to a
number of risks and uncertainties that may cause the actual results
of MustGrow to differ materially from those discussed in such
forward-looking statements, and even if such actual results are
realized or substantially realized, there can be no assurance that
they will have the expected consequences to, or effects on,
MustGrow.
These risks are described in more detail in
MustGrow’s Prospectus and other continuous disclosure documents
filed by MustGrow with the applicable securities regulatory
authorities and available at www.sedar.com. Readers are
referred to such documents for more detailed information about
MustGrow, which is subject to the qualifications, assumptions and
notes set forth therein.
This release does not constitute an offer for
sale of, nor a solicitation for offers to buy, any securities in
the United States. Neither the CSE nor its Regulation Services
Provider (as that term is defined in the policies of the CSE)
accepts responsibility for the adequacy or accuracy of this
release.
Important
Always read and follow label use directions. ©
2019 MustGrow Biologics Corp. All rights reserved.
MustGrow Biologics (CSE:MGRO)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
MustGrow Biologics (CSE:MGRO)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024